
Bruck Kifle
Examiner (ID: 2332, Phone: (571)272-0668 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 1624, 1611, 1622 |
| Total Applications | 3434 |
| Issued Applications | 2601 |
| Pending Applications | 222 |
| Abandoned Applications | 651 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16777969
[patent_doc_number] => 20210115046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/464341
[patent_app_country] => US
[patent_app_date] => 2017-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464341
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/464341 | Pyrazolo-heteroaryl derivative, preparation method and medical use thereof | Nov 26, 2017 | Issued |
Array
(
[id] => 13037367
[patent_doc_number] => 10040803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-07
[patent_title] => 4-((2-acrylamidophenyl)amino)thieno[3,2-D]pyrimidine-7-carboxamide derivatives as protein kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/821962
[patent_app_country] => US
[patent_app_date] => 2017-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4528
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15821962
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/821962 | 4-((2-acrylamidophenyl)amino)thieno[3,2-D]pyrimidine-7-carboxamide derivatives as protein kinase inhibitors | Nov 23, 2017 | Issued |
Array
(
[id] => 14777851
[patent_doc_number] => 20190263823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => DEGRADATION OF PROTEIN KINASES BY CONJUGATION OF PROTEIN KINASE INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/343977
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343977
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/343977 | Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use | Nov 21, 2017 | Issued |
Array
(
[id] => 12239823
[patent_doc_number] => 20180072686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => '5-FLUORO-4-IMINO-3-(ALKYL/SUBSTITUTED ALKYL)-1-(ARYLSULFONYL)-3,4-DIHYDROPYRIMIDIN-2(1H)-ONE AND PROCESSES FOR THEIR PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 15/813562
[patent_app_country] => US
[patent_app_date] => 2017-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3026
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15813562
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/813562 | 5-FLUORO-4-IMINO-3-(ALKYL/SUBSTITUTED ALKYL)-1-(ARYLSULFONYL)-3,4-DIHYDROPYRIMIDIN-2(1H)-ONE AND PROCESSES FOR THEIR PREPARATION | Nov 14, 2017 | Abandoned |
Array
(
[id] => 13478979
[patent_doc_number] => 20180291032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => POLYMORPHOUS FORMS OF RIFAXIMIN, PROCESSES FOR THEIR PRODUCTION AND USE THEREOF IN THE MEDICINAL PREPARATIONS
[patent_app_type] => utility
[patent_app_number] => 15/811536
[patent_app_country] => US
[patent_app_date] => 2017-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15811536
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/811536 | POLYMORPHOUS FORMS OF RIFAXIMIN, PROCESSES FOR THEIR PRODUCTION AND USE THEREOF IN THE MEDICINAL PREPARATIONS | Nov 12, 2017 | Abandoned |
Array
(
[id] => 13116395
[patent_doc_number] => 10076533
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-18
[patent_title] => Acyclic nucleoside phosphonate diesters
[patent_app_type] => utility
[patent_app_number] => 15/809400
[patent_app_country] => US
[patent_app_date] => 2017-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28196
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15809400
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/809400 | Acyclic nucleoside phosphonate diesters | Nov 9, 2017 | Issued |
Array
(
[id] => 16991702
[patent_doc_number] => 20210230122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => 5-FLUOROURACIL DERIVATIVES, PREPARATION METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/762238
[patent_app_country] => US
[patent_app_date] => 2017-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10817
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762238
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/762238 | 5-fluorouracil derivatives, preparation methods and uses thereof | Nov 8, 2017 | Issued |
Array
(
[id] => 15178047
[patent_doc_number] => 20190359615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => ISOQUINOLINE ETHER COMPOUNDS AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/348474
[patent_app_country] => US
[patent_app_date] => 2017-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20618
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348474
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348474 | Isoquinoline ether compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | Nov 7, 2017 | Issued |
Array
(
[id] => 13814387
[patent_doc_number] => 10183954
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-22
[patent_title] => Oxathiolane carboxylic acids and derivatives for the treatment and prophylaxis of virus infection
[patent_app_type] => utility
[patent_app_number] => 15/806635
[patent_app_country] => US
[patent_app_date] => 2017-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13568
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15806635
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/806635 | Oxathiolane carboxylic acids and derivatives for the treatment and prophylaxis of virus infection | Nov 7, 2017 | Issued |
Array
(
[id] => 17571056
[patent_doc_number] => 11319314
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-03
[patent_title] => Phenoxytriazoles
[patent_app_type] => utility
[patent_app_number] => 16/348322
[patent_app_country] => US
[patent_app_date] => 2017-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72040
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348322
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348322 | Phenoxytriazoles | Nov 5, 2017 | Issued |
Array
(
[id] => 12233089
[patent_doc_number] => 20180065952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'COMPOUNDS TARGETING PROTEINS, COMPOSITIONS, METHODS, AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/801124
[patent_app_country] => US
[patent_app_date] => 2017-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 22644
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15801124
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/801124 | Compounds targeting proteins, compositions, methods, and uses thereof | Oct 31, 2017 | Issued |
Array
(
[id] => 13763341
[patent_doc_number] => 10174005
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => Fused pyrimidines as inhibitors of p97 complex
[patent_app_type] => utility
[patent_app_number] => 15/792514
[patent_app_country] => US
[patent_app_date] => 2017-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40953
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15792514
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/792514 | Fused pyrimidines as inhibitors of p97 complex | Oct 23, 2017 | Issued |
Array
(
[id] => 14198877
[patent_doc_number] => 10266531
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-23
[patent_title] => Naphthyridinone derivatives and their use in the treatment of arrhythmia
[patent_app_type] => utility
[patent_app_number] => 15/788248
[patent_app_country] => US
[patent_app_date] => 2017-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 29024
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15788248
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/788248 | Naphthyridinone derivatives and their use in the treatment of arrhythmia | Oct 18, 2017 | Issued |
Array
(
[id] => 13196131
[patent_doc_number] => 10112975
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => Benzodiazepine dimers, conjugates thereof, and methods of making and using
[patent_app_type] => utility
[patent_app_number] => 15/785675
[patent_app_country] => US
[patent_app_date] => 2017-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 33559
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15785675
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/785675 | Benzodiazepine dimers, conjugates thereof, and methods of making and using | Oct 16, 2017 | Issued |
Array
(
[id] => 12178645
[patent_doc_number] => 20180037581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'HETEROARYLENE-BRIDGED BENZODIAZEPINE DIMERS, CONJUGATES THEREOF, AND METHODS OF MAKING AND USING'
[patent_app_type] => utility
[patent_app_number] => 15/785608
[patent_app_country] => US
[patent_app_date] => 2017-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 33918
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15785608
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/785608 | HETEROARYLENE-BRIDGED BENZODIAZEPINE DIMERS, CONJUGATES THEREOF, AND METHODS OF MAKING AND USING | Oct 16, 2017 | Abandoned |
Array
(
[id] => 14145363
[patent_doc_number] => 10253040
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-04-09
[patent_title] => MK2 inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/782995
[patent_app_country] => US
[patent_app_date] => 2017-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57668
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15782995
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/782995 | MK2 inhibitors and uses thereof | Oct 12, 2017 | Issued |
Array
(
[id] => 14864927
[patent_doc_number] => 20190282705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => PYRROLOBENZODIAZEPINE CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 16/340973
[patent_app_country] => US
[patent_app_date] => 2017-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16340973
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/340973 | Pyrrolobenzodiazepine conjugates | Oct 12, 2017 | Issued |
Array
(
[id] => 14624481
[patent_doc_number] => 20190225608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => NOVEL POLYMORPH OF AN INTERMEDIATE FOR PALBOCICLIB SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 16/338832
[patent_app_country] => US
[patent_app_date] => 2017-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2369
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16338832
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/338832 | Polymorph of an intermediate for palbociclib synthesis | Oct 3, 2017 | Issued |
Array
(
[id] => 12624453
[patent_doc_number] => 20180099981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => COMPOUNDS, COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 15/721470
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 112574
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721470
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/721470 | Compounds, compositions and methods | Sep 28, 2017 | Issued |
Array
(
[id] => 12192742
[patent_doc_number] => 09896458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-20
[patent_title] => 'Compounds, compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 15/721419
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 157101
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721419
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/721419 | Compounds, compositions and methods | Sep 28, 2017 | Issued |